Dr. Bray Links

Wednesday, November 14, 2018

AHA.18: VITAL, REDUCE-IT deliver mixed results for fish oil products

VITAL and REDUCE-IT—both highly anticipated trials revolving around the cardiovascular benefits of fish oil products—delivered mixed results at this year's AHA Scientific Sessions in Chicago, with one trial observing few heart benefits from omega-3s while the other saw a 25 percent reduction in major cardiovascular events with a purified eicosapentaenoic acid (EPA) product.


No comments:

Post a Comment

Note: Only a member of this blog may post a comment.